Mathieu Streiff Acquires Shares in American Healthcare REIT
Insider Mathieu Streiff purchased 2,594 shares of American Healthcare REIT on June 24, 2026.
Key Points
- Mathieu Streiff purchased 2,594 shares of American Healthcare REIT on June 24, 2026, reflecting insider confidence.
- American Healthcare REIT has a market cap of $10.53 billion, a P/E ratio of 86.31, and trades near $51.48.
- Analysts from firms like Scotiabank and Keybanc maintain a 'buy' rating with targets ranging from $51 to $60.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Mathieu Streiff, an insider at American Healthcare REIT, Inc. (NYSE:AHR), purchased 2,594 shares of the company on June 24, 2026. This transaction highlights insider confidence as the stock traded near $51.48 on Saturday.
American Healthcare REIT, Inc. Stock Down 7.3%
Shares of NYSE:AHR traded near $51.48 on Saturday. American Healthcare REIT has a market cap of about $10.53 billion and a P/E ratio of 86.31. The company’s stock has seen a 52-week range between $35.52 and $54.67. Its 50-day moving average stands at $49.15, while the 200-day moving average is $47.81. The stock’s beta is 0.805, indicating lower volatility compared to the market.
$AHR stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at American Healthcare REIT, Inc.
On June 24, 2026, several insiders, including Scott Estes, Brian Flornes, Dianne Hurley, Marvin O'Quinn, Wilbur Smith III, and Valerie Richardson, each purchased 2,594 shares of American Healthcare REIT. These transactions were not part of any pre-planned trading programs, reflecting direct insider interest in the company’s stock.
Analysts Set New Price Targets
Analysts are optimistic about American Healthcare REIT, with multiple firms maintaining 'buy' ratings. On June 18, 2026, Scotiabank maintained its 'buy' rating with a price target of $51. Keybanc followed suit on May 28, 2026, maintaining a 'buy' rating and setting a target of $58. RBC Capital also maintained a 'buy' rating with a $56 target on May 26, 2026. The overall analyst consensus remains strong, with a mean target price of $58.23 based on 13 opinions.
About American Healthcare REIT
American Healthcare REIT, Inc., based in Irvine, California, is a self-managed real estate investment trust (REIT) focusing on healthcare facilities. It operates a diverse portfolio of senior housing, skilled nursing facilities, outpatient medical buildings, and other healthcare properties across the U.S., U.K., and the Isle of Man. The company, led by CEO Jeffrey T. Hanson, employs 121 people and aims to generate income through its real estate investments.
Bottom Line
Mathieu Streiff's recent purchase of shares in American Healthcare REIT underscores insider confidence in the company. Investors often track these transactions as potential indicators of a company's future performance. However, it's important to remember that insider trades are just one piece of the puzzle. This activity, along with the company's market position and analyst ratings, provides a fuller picture of its potential.
Get American Healthcare REIT, Inc. alerts
New 13F filings, insider trades, and analyst moves on $AHR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.